The last year (and particularly the last few months) of the Biden Administration brought a flurry of activity from the Federal Trade Commission ...

Daniel L. Forman of Lowenstein Sandler LLP discusses key disclosure considerations for securities 10-K filings as companies ...

The bot, which will be available for preorder this year, walks, talks, washes dishes and clothes, makes sandwiches and pours ...

Tiziana Life Sciences Ltd., a biotechnology company pioneering breakthrough immunomodulation therapies, has entered a ...

The $1.15 billion innovation hub on UC Davis’ Sacramento campus is expected to drive $500 million in annual economic output ...

Seer's management is scheduled to participate in a fireside chat on Tuesday, March 4 th at 11:50 a.m. Eastern Time / 8:50 a.m. Pacific Time. A live webcast of the session will be available on the ...

The Philadelphia market has gained recognition not only for its cell and gene therapy sector but also its real estate scene and talent pool. Vittoria Biotherapeutics, Interius BioTherapeutics and ...

Colossal Biosciences cofounder and CEO Ben Lamm is worth $3.7 billion following the company's recent fundraise at an ...

What considerations should developers in Denver-Boulder keep in mind when planning future life sciences facilities, particularly around the flexibility required for evolving technologies?

By owning a substantial senior housing operating portfolio, Ventas has unlocked value in its most favorable assets, but this also leads to a greater degree of volatility and financial risk versus the ...